<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03413891</url>
  </required_header>
  <id_info>
    <org_study_id>S60131</org_study_id>
    <nct_id>NCT03413891</nct_id>
  </id_info>
  <brief_title>Tranexamic Acid To Reduce Bleeding in Patients Treated With New Oral Anticoagulants Undergoing Dental Extraction</brief_title>
  <acronym>EXTRACT-NOAC</acronym>
  <official_title>Tranexamic Acid To Reduce Bleeding in Patients Treated With New Oral Anticoagulants Undergoing Dental Extraction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Research Foundation Flanders</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients treated with direct oral anticoagulants, bleeding events during or after tooth
      extraction can lead to unscheduled interruption of the antithrombotic treatment and a
      potential increased risk of thrombo-embolic events. Therefore, an optimal strategy to
      minimize bleeding events after tooth extractions is required. In this study, the
      investigators want to assess whether adding tranexamic acid mouthwash reduces the number of
      bleeding events in patients treated with direct oral anticoagulants and undergoing a tooth
      extraction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interventional phase IV, randomized, double-blind, placebo-controlled trial:

        -  Feasibility: a 3-day regimen of tranexamic acid mouthwash in patients treated with
           direct oral anticoagulants

        -  Efficacy: reduction of bleeding events after tooth extraction compared to placebo

        -  Safety: any non-oral bleeding or thrombo-embolic events
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 17, 2018</start_date>
  <completion_date type="Anticipated">February 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 17, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oral bleeding</measure>
    <time_frame>7 days: from randomization till end of follow-up</time_frame>
    <description>Any oral bleeding (early or delayed; minor, clinically relevant or major)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural bleeding score</measure>
    <time_frame>Day of extraction</time_frame>
    <description>Bleeding score assigned by operator (VAS 0-10)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early bleeding</measure>
    <time_frame>1 day</time_frame>
    <description>Any oral bleeding occurring after the extraction up to and including day 1 after the extraction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delayed bleeding</measure>
    <time_frame>6 days</time_frame>
    <description>Any oral bleeding occurring between day 2 and day 7</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minor bleeding</measure>
    <time_frame>7 days</time_frame>
    <description>Any oral bleeding not requiring unplanned medical contact</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinically-relevant bleeding</measure>
    <time_frame>7 days</time_frame>
    <description>Any oral bleeding requiring unplanned medical contact</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major bleeding</measure>
    <time_frame>7 days</time_frame>
    <description>Any oral bleeding requiring blood transfusion, hospitalization or resulting in death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of reinterventions</measure>
    <time_frame>7 days</time_frame>
    <description>Any procedure in the oral cavity for the treatment of bleeding, performed by any dentist or maxillofacial surgeon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of unplanned interruptions of direct oral anticoagulant therapy</measure>
    <time_frame>7 days</time_frame>
    <description>The number of unplanned interruptions of direct oral anticoagulant therapy</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Safety outcome: any non-oral bleeding</measure>
    <time_frame>7 days</time_frame>
    <description>Any non-oral bleeding</description>
  </other_outcome>
  <other_outcome>
    <measure>Safety outcome: thrombotic event</measure>
    <time_frame>7 days</time_frame>
    <description>All thrombotic events including myocardial infarction, stroke, systemic embolism and venous thrombo-embolism</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">236</enrollment>
  <condition>Tooth Extraction</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>10mL water as mouthwash with white cherry flavor in oral syringes. Once before tooth extraction and 3 times daily during 3 days post-extraction (starting day after extraction).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tranexamic Acid Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10mL tranexamic acid mouthwash 10% in oral syringes. Once before tooth extraction and 3 times daily during 3 days post-extraction (starting day after extraction).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic Acid</intervention_name>
    <description>Mouthwash</description>
    <arm_group_label>Tranexamic Acid Group</arm_group_label>
    <other_name>Exacyl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Mouthwash</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for dental extraction and treated with edoxaban, apixaban,
             rivaroxaban or dabigatran

          -  Not having taken the direct oral anticoagulant on the day of the extraction

          -  Provision of signed and dated informed consent form

          -  Stated willingness to comply with all study procedures and availability for the
             duration of the study

        Exclusion Criteria:

          -  Subjects with any condition that as judged by the Investigator would place the subject
             at increased risk of harm if he/she participated in the study.

          -  Pregnancy or lactation

          -  Known allergic reaction to tranexamic acid
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Peter Verhamme, MD, PhD</last_name>
    <phone>003216343491</phone>
    <email>peter.verhamme@uzleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Val√©rie Robesyn</last_name>
    <phone>003216341949</phone>
    <email>blv@uzleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Verhamme, MD, PhD</last_name>
      <phone>003216343491</phone>
      <email>peter.verhamme@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Constantinus Politis, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Ockerman, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Vanassche, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Isabel Miclotte, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maarten Vanhaverbeke, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2018</study_first_submitted>
  <study_first_submitted_qc>January 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2018</study_first_posted>
  <last_update_submitted>January 26, 2018</last_update_submitted>
  <last_update_submitted_qc>January 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Peter Verhamme</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Anticoagulants</keyword>
  <keyword>Tranexamic Acid</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
    <mesh_term>Anticoagulants</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

